CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Reports Positive Results from Skin Absorption Study
Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) this morning said that it has completed the first study evaluating DehydraTECH™ used in a topical cream formulation for absorption of cannabidiol ("CBD") through human skin. Compared to control formulations, significant increases in the speed and quantity of CBD absorption through skin were proven in the study. Several factors were measured during the study at multiple testing intervals over a 48-hour duration, including the time required to detect CBD skin penetration and quantity as well as the peak amounts of CBD absorbed. Lexaria's DehydraTECH-enabled topical formulation without the addition of either of the commercial…